Ahmed Faheem, Osman Nadia, Lucas Fred, Neff Guy, Smolarek Teresa, Bennett John M, Komrokji Rami S
Department of Internal Medicine, Hematology and Medical Oncology Division, University of Cincinnati, Cincinnati, OH, USA.
Int J Hematol. 2009 Jun;89(5):699-703. doi: 10.1007/s12185-009-0318-1. Epub 2009 May 9.
Therapy related chronic myelomonocytic leukemia (t-CMML) is rare. We report a 23-year-old female who developed acute fulminant hepatic failure after drug overdose. She underwent ABO incompatible orthotopic liver transplant. She received cyclophosphamide along with other immunosuppressants. Seven years later, she was diagnosed with t-CMML-2 with 45XX,-7 karyotype. She received 4 cycles of azacitidine and proceeded with allogeneic bone marrow transplant. This is the first a case of t-CMML reported in a liver transplant recipient. In this article, we also summarize all reported cases of t-CMML, and we review therapy related MDS in recipients of solid organ transplant.
治疗相关的慢性粒单核细胞白血病(t-CMML)较为罕见。我们报告了一名23岁女性,她在药物过量后发生急性暴发性肝衰竭。她接受了ABO血型不相容的原位肝移植。她接受了环磷酰胺及其他免疫抑制剂治疗。七年后,她被诊断为t-CMML-2,核型为45XX,-7。她接受了4个周期的阿扎胞苷治疗,随后进行了异基因骨髓移植。这是首例在肝移植受者中报告的t-CMML病例。在本文中,我们还总结了所有已报告的t-CMML病例,并回顾了实体器官移植受者中与治疗相关的骨髓增生异常综合征。